Results 81 to 90 of about 3,400,908 (256)

INFLUENCE OF DOSE RATE ON THE CELLULAR RESPONSE TO LOW- AND HIGH-LET RADIATIONS

Frontiers in Oncology, 2016
Nowadays, head and neck squamous cell carcinoma (HNSCC) treatment failure is mostly explained by loco-regional progression or intrinsic radioresistance.
Anne-Sophie eWozny, Anne-Sophie eWozny, Gersende eAlphonse, Gersende eAlphonse, Priscillia eBattiston-Montagne, Stéphanie eSimonet, Delphine ePoncet, Delphine ePoncet, Etienne eTesta, Jean-Baptiste eGuy, Jean-Baptiste eGuy, Chloé eRancoule, Nicolas eMagne, Michael eBeuve, Claire eRodriguez-Lafrasse, Claire eRodriguez-Lafrasse   +15 more
doaj   +1 more source

Quercetin‐zinc coordination polymer coated CaCO3 nanoparticles potentiate radiotherapy through reprogramming tumor immunosuppression

BMEMat, EarlyView.
Synthesis of QZCaCO3‐PEG to synergistically enhance the immunogenicity of radiotherapy through concurrent Zn2+‐induced cancer cell pyroptosis and Que‐mediated hypoxia amelioration through sequentially suppressing TGF‐β secretion and ECM deposition. Abstract Radiotherapy has demonstrated broad applications in treating solid tumors, but the hostile tumor
Chunjie Wang, Hengze Ding, Yu Hao, Honglin An, Ziliang Dong, Minming Chen, Yujie Zhu, Quguang Li, Bin Huang, Liangzhu Feng   +9 more
wiley   +1 more source

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

BMC Cancer, 2010
Background Treatment of patients with recurrent glioma includes neurosurgical resection, chemotherapy, or radiation therapy. In most cases, a full course of radiotherapy has been applied after primary diagnosis, therefore application of re-irradiation ...
Haselmann Renate, Haberer Thomas, Jäkel Oliver, Habermehl Daniel, Rieken Stefan, Edler Lutz, Burkholder Iris, Combs Stephanie E, Unterberg Andreas, Wick Wolfgang, Debus Jürgen   +10 more
doaj   +1 more source

Overview of Carbon Ion Radiotherapy at NIRS-HIMAC

, 2017
No avilable abstract.
Kamada, Tadashi, 654186, 654187, 鎌田 正   +3 more
core  

Nanomedicine‐driven innovations in postoperative cancer immunotherapy: Remodeling tumor microenvironment and precision delivery strategies

BMEMat, EarlyView.
Nanomedicine‐Driven Strategies for Suppressing Postoperative Tumor Recurrence. This schematic illustrates three pivotal nanomedical strategies that synergistically counteract recurrence by targeting residual disease and the immunosuppressive tumor microenvironment within the surgical cavity.
Lisong Pang, Zhuomin Wang, Zhenhua Jin, Ahmed H. Ghonaim, Hengcheng Zhang, Xinyu You, Jinzhuo Ning, Jiaqing Cao, Yang Liu   +8 more
wiley   +1 more source

Influence of 6‐Trifluoromethyluracil Versus Chloride Counterions in the Properties of Bis‐(1,10‐Phenanthroline)chloridecopper(II) Motif: Spectroscopic and In Vitro Biological Activity Assays

European Journal of Inorganic Chemistry, EarlyView.
This work explores the influence of 6‐trifluoromethyluracil versus chloride counterions on the antibacterial and antitumoral activities of bis‐(1,10‐phenanthroline)chloridecopper(II) motif. The counterion modulates antibacterial potency and the identity of the dominant reactive species, while leaving DNA recognition by the shared cation essentially ...
Francisco Mastrobuono‐Cordeiro, Gabriele de M. Pereira, Douglas H. Nakahata, Stefano Scoditti, Fernanda V. P. de V. Azevedo, Letícia P. de Oliveira, Silmara C. L. Frajácomo, Javier Ellena, Pedro H. de O. Santiago, Daniel Reta, Gilberto C. Franchi, Wilton R. Lustri, Carmen S. P. Lima, Pedro P. Corbi, Raphael E. F. de Paiva   +14 more
wiley   +1 more source

Proteomic and Metabolomic Profiling Reveal Mitochondrial Transplantation–Mediated Reprogramming in Gastric Cancer Cells

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Mitochondria provide multiple functions for cellular physiology. Transplantation of mitochondria isolated from gastric epithelial cells GES‐1 reducing the malignancy of gastric cancer cells AGS was previously reported. To elucidate the underlying mechanisms, TMT‐based proteomic analysis coupling ingenuity pathway software prediction revealed ...
Ping‐Chen Chen, Chen‐Kai Liu, Ching‐Chung Tsai, Erna Sulistyowati, Fu‐An Li, Chung‐Jung Liu, Deng‐Chyang Wu, Shih‐Hsuan Chou, Fu‐Chen Kuo, Bin Huang   +9 more
wiley   +1 more source

Carbon Ion Radiotherapy for Pancreatic Cancer

, 2010
The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world first heavy ion accelerator complex dedicated to medical use in a hospital environment.
安田 茂雄, Shinoto, Makoto, Yasuda, Shigeo, 篠藤 誠, 643488, 554154, 554155, 554156, 554157, 554150, 554151, 554152, 554153, Oonishi, Kazuhiko, 554147, 554148, 554149, Imada, Hiroshi, 辻井 博彦, 大西 和彦, 643494, 643495, 643492, 554160, 643493, 643498, 643499, 643496, 643497, 643490, 鎌田 正, 643491, Tsujii, Hirohiko, Kamada, Tadashi, 554158, 554159, 山田 滋, 今田 浩史, Yamada, Shigeru, 643489, 643500, 643501   +41 more
core  

History, current status and prospects of proton and heavy ion radiotherapy for tumors

Zhongguo aizheng zazhi
Proton and heavy ions were discovered a century ago. Compared with conventional X-ray beams, proton and heavy ion beams exhibit unique superiorities in radiophysical dose distribution.
JIANG Guoliang
doaj  

Current Status of Carbon Ion Radiotherapy in Japan

, 2011
As compared to photon beams, carbon ion beams offer improved dose distributions in cancer radiotherapy, thus enabling dose concentration within a target volume while minimizing the dose in the surrounding normal tissues.
Tsujii, Hirohiko, 555724, 555725, 635498, 635497, 辻井 博彦   +5 more
core